Pittcon 2023:Meling Biomedical Will Attend

The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy（Pittcon） was firstly held in 1950 in Pennsylvania, USA and organized by a non-profit academic organization which is jointly formed by the Spectroscopy Society of Pittsburgh and the Society for Analytical Chemists of Pittsburgh. Pittcon is known as one of the most ancient laboratory instrument and technology exhibition in North America and the premier annual conference and exposition on laboratory science.

With a long history and high reputation,PITTCON has developed into a comprehensive trade fair.According to official data, in 2020, there were 713 exhibitors from 88 countries , about 22%  from Canada, China, France, Germany, Italy, Japan, the Netherlands and the United Kingdom and visitors from more than 90 countries in the global. The 71th Pittcon is scheduled on March 18-22, 2023, in Philadelphia, PA, USA after two years’ hiatus because of global pandemic.

Meling Biomedical has enrollment in the Pittcon 2023 as early as last year.Meling Team makes every effort to do the preparations in order to bring visitors and users a better service at the site. At present, pre-exhibition activities such as construction and electricity are in full swing. What’s more Meling Biomedical will present the new upgraded freezers to the exhibition.

As one of the pioneers in China's refrigeration industry, Meling Biomedical actively responds to the going- out strategy to attend abroad exhibitions. And Meling members  will also make full use of the platform of Pittcon to“advance scientific endeavor through collaboration, bringing together a world of knowledge to impact, enrich, and inspire the future of science”and share and exchange ”the latest advances in laboratory science and make more international connectivity” with refrigeration industry peers,which is also Pittcon’s goal. In the near future, Meling Biomedical will contribute to the further development of the refrigeration industry and life and health sciences in the post-epidemic era.